Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death. 摘要 前列腺癌术后的放疗与否以及放疗的最佳时期一直是一个争议性的话题。近期,一项发表在JCO上的研究探索了前列腺癌患者根治性切除术后进行辅助放疗(adjuvant radiation therapy, a...
STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer? - ScienceDirectAnanya Choudhury MA, PhD, MRCP, FRCRRonald C. Chen MD, MPHAnn Henry MD, FRCRHitesh Mistry PhD §Timur Mitin MD, PhD ‖...
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death. 摘要 前列腺癌术后的放疗与否以及放疗的最佳时期一直是一个争议性的话题。近期,一项发表在JCO上的研究探索了前列腺癌患者根治性切除术后进行辅助放疗(adjuvant radiation therapy, aRT)对比早...
在STAMPEDE 试验中随机分配接受多西他赛或阿比特龙治疗的前列腺癌男性的生活质量 Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. 摘要 《临床肿瘤学杂志( JCO )》在2022年发表了一篇关于多西他赛或阿比特龙治疗的前列腺癌男性的生活质量的研究。
MPORTANCE: The natural history of patients with newly diagnosed high-risk nonmetastatic (M0) prostate cancer receiving hormone therapy (HT) either alone or with standard-of-care radiotherapy (RT) is not well documented. Furthermore, no clinical trial has assessed the role of RT in patients wit...
Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) is a randomized controlled trial that follows a novel multi-arm, multi-stage (MAMS) design. We describe methodological and practical issues arising with (1) stopping recruitment to research arms followi...
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial Home > Section > Chapter James, N.D.; Sydes, M.R.; Mason, M.D.; Clarke, N.W.; Anderson, J.; Dearnaley, D....
Local Prostate Radiation Therapy and Symptomatic Local Events in De Novo Metastatic Prostate Cancer Metastatic burden was defined per the STAMPEDE trial. Results:Of 1363 patients, 46 (3.4%) received LPRT. Median follow-up was 27.3 and 28.9 months in the control and LPRT groups, respectively. LP...
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. 摘要 《临床肿瘤学杂志(JCO)》在2022年发表了一篇关于多西他赛或阿比特龙治疗的前列腺癌男性的生活质量的研究。由于...